pI: 6.6871 |
Length (AA): 274 |
MW (Da): 31082 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 2
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_130604)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G43690 | ubiquitin interaction motif-containing protein |
Babesia bovis | BBOV_III009050 | hypothetical protein |
Cryptosporidium hominis | Chro.30416 | hypothetical protein |
Cryptosporidium parvum | cgd3_3680 | UIM domain and EF hand containing protein that also has a conserved domain between |
Drosophila melanogaster | Dmel_CG7332 | CG7332 gene product from transcript CG7332-RB |
Echinococcus granulosus | EgrG_001011700 | protein FAM188A |
Echinococcus multilocularis | EmuJ_001011700 | protein FAM188A |
Homo sapiens | ENSG00000148481 | family with sequence similarity 188, member A |
Mus musculus | ENSMUSG00000026767 | family with sequence similarity 188, member A |
Neospora caninum | NCLIV_013860 | F2J6.5 protein, related |
Oryza sativa | 4335833 | Os04g0421800 |
Plasmodium berghei | PBANKA_1129400 | conserved protein, unknown function |
Plasmodium falciparum | PF3D7_0630600 | conserved protein, unknown function |
Plasmodium knowlesi | PKNH_1118900 | conserved protein, unknown function |
Plasmodium vivax | PVX_114630 | hypothetical protein, conserved |
Plasmodium yoelii | PY04518 | Mus musculus RIKEN cDNA 2310047O13 gene |
Schistosoma japonicum | Sjp_0053940 | Protein CARP, putative |
Schistosoma mansoni | Smp_181460 | hypothetical protein |
Toxoplasma gondii | TGME49_286800 | hypothetical protein |
Theileria parva | TP04_0809 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_476550 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_106700 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
TGME49_286800 | Toxoplasma gondii | Essentiality uncertain | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.